Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Pfe save search
Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.1%
H: 0.52%
C: 0.36%
ARVN | $34.78 1.43% 1.41% 940K
|
Health Technology
|
| O: 1.86%
H: 5.16%
C: -4.27%
arv-471 breast cancer medical
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.1%
H: 0.52%
C: 0.36%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: -4.4%
update financial results
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-05 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.31%
C: 0.29%
ARVN | $34.78 1.43% 1.41% 940K
|
Health Technology
|
| O: 2.04%
H: 5.9%
C: 5.46%
update financial results
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-04 (Crawled : 12:20) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.73%
H: 0.68%
C: 0.16%
INSM | $24.4 -1.61% -1.64% 5.5M
|
Health Technology
|
| O: -1.11%
H: 3.47%
C: -0.1%
business update financial results
Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18.1 Billion by 2030 at a 42.5% CAGR
Published: 2023-05-03 (Crawled : 18:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.73%
H: 0.68%
C: 0.16%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.06%
H: 0.29%
C: -0.7%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.29%
H: 1.19%
C: 0.56%
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: -0.38%
H: 1.38%
C: 1.2%
LXRX | $1.655 1.53% 1.51% 3M
|
Health Technology
|
| O: 2.19%
H: 13.21%
C: 10.0%
report reach global duchenne market
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Published: 2023-05-03 (Crawled : 12:20) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.36%
H: 0.48%
C: -1.91%
DCPH | $14.69 3.23% 3.13% 390K
|
Health Technology
|
| O: -6.99%
H: 7.22%
C: 4.74%
pharmaceuticals financial results
GlycoEra AG Expands Board of Directors and Appoints Santiago Arroyo, MD to its Board of Directors as an independent board member
Published: 2023-05-02 (Crawled : 13:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.45%
H: 0.69%
C: 0.42%
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy
Published: 2023-05-02 (Crawled : 12:20) - mindmed.co
MNMD | $8.7 -2.36% -2.41% 1.5M
|
n/a
|
| O: -1.04%
H: 0.79%
C: -1.06%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
ALC | $79.55 1.38% -0.25% 1.1M
|
Health Technology
|
| O: -0.69%
H: 0.77%
C: 0.11%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.28%
H: 0.32%
C: 0.11%
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: -0.5%
H: 0.74%
C: -2.58%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -9.64%
H: 5.99%
C: 2.76%
FBRX 4 | $0.78 5.13% 8.3K
|
Health Technology
|
| O: -1.85%
H: 4.72%
C: 0.94%
momentum positive
Pfizer Reports First-Quarter 2023 Results
Published: 2023-05-02 (Crawled : 12:20) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.2%
H: 2.1%
C: -0.59%
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: -0.52%
H: 0.44%
C: -2.29%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.84%
H: 2.03%
C: 0.01%
results
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
Published: 2023-03-31 (Crawled : 14:20) - globenewswire.com
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -2.05%
H: 11.75%
C: -2.1%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.42%
H: 0.69%
C: 0.62%
CLSD P | $1.29 -2.27% -2.33% 230K
|
Health Technology
|
| O: 2.4%
H: 7.14%
C: 6.12%
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 1.07%
H: 0.94%
C: -1.65%
XTANDI® (enzalutamide) plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide
Published: 2023-04-29 (Crawled : 16:20) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
| Email alert
Add to watchlist
ALPMF | $9.17 43.47% 16K
|
Health Technology
| Email alert
Add to watchlist
xtandi cancer risk plus
U.S. FDA Approves PREVNAR 20®, Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
Published: 2023-04-27 (Crawled : 22:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.03%
H: 0.54%
C: 0.31%
fda pneumococcal children vaccine
Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit
Published: 2023-04-26 (Crawled : 01:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.43%
H: 0.08%
C: -1.35%
pharma business
Stomach Cancer Treatment Market Report 2023: Growing Demand for Painless Low-Cost Treatment and Favorable Reimbursement Scenarios Bolsters Sector
Published: 2023-04-14 (Crawled : 02:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.08%
H: 0.49%
C: -0.76%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.24%
H: 0.55%
C: 0.13%
report favorable cancer treatment growing market
Pfizer Invites Shareholders to Attend Virtual-Only 2023 Annual Meeting of Shareholders on April 27
Published: 2023-04-13 (Crawled : 16:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.39%
H: 0.41%
C: -0.14%
meeting
Arbutus Biopharma and Genevant Sciences File Patent Infringement Lawsuit Against Pfizer/BioNTech
Published: 2023-04-04 (Crawled : 12:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -1.3%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.05%
H: 0.89%
C: -2.88%
ABUS | $2.725 -0.18% -0.18% 930K
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: -2.29%
patent biopharma sciences
FDA Accepts Pfizer’s Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
Published: 2023-04-04 (Crawled : 11:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -1.3%
fda drug
Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer
Published: 2023-04-04 (Crawled : 03:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -1.3%
australia group acquisition
Researchers Show Lorlatinib is Safe and Effective for Patients with ALK-Driven Relapsed/Refractory High-Risk Neuroblastoma
Published: 2023-04-03 (Crawled : 18:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.27%
H: 1.91%
C: 1.62%
show
Vaccinex Reports 2022 Financial Results and Provides Corporate Update of Continued Progress in Neurology and Oncology Clinical Programs
Published: 2023-04-03 (Crawled : 12:00) - ir.vaccinex.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.27%
H: 1.91%
C: 1.62%
VCNX | $4.8 -2.76% 7.9K
|
Health Technology
|
| O: 0.13%
H: 10.0%
C: 5.5%
update financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.